Literature DB >> 11676757

Prescription of activity for low back pain: What works?

Christopher Maher1, Jane Latimer, Kathryn Refshauge.   

Abstract

This paper provides evidence-based guidelines for the prescription of activity in the management of non-specific low back pain (NSLBP). The 62 clinical trials published between 1966 and 1997, identified by a search of the Medline and Cinahl databases, were reviewed to provide the basis for the guidelines. The available evidence suggests that physiotherapists should advise patients with acute and sub-acute NSLBP to avoid bed rest and to return to normal activity using time rather than pain as the guide to activity resumption. While structured exercise programs have not been shown to provide a benefit for acute NSLBP, there is strong evidence to support their use for patients with sub-acute and chronic NSLBP and in the prevention of NSLBP.

Entities:  

Year:  1999        PMID: 11676757     DOI: 10.1016/s0004-9514(14)60344-5

Source DB:  PubMed          Journal:  Aust J Physiother        ISSN: 0004-9514


  4 in total

Review 1.  Low back pain investigations and prognosis: a review.

Authors:  K M Refshauge; C G Maher
Journal:  Br J Sports Med       Date:  2006-06       Impact factor: 13.800

2.  A randomized controlled trial of tai chi for long-term low back pain (TAI CHI): study rationale, design, and methods.

Authors:  Amanda M Hall; Chris G Maher; Jane Latimer; Manuela L Ferreira; Paul Lam
Journal:  BMC Musculoskelet Disord       Date:  2009-05-28       Impact factor: 2.362

3.  Effects of preferred-exercise prescription compared to usual exercise prescription on outcomes for people with non-specific low back pain: a randomized controlled trial [ACTRN12608000524392].

Authors:  Susan C Slade; Jennifer L Keating
Journal:  BMC Musculoskelet Disord       Date:  2009-01-28       Impact factor: 2.362

4.  Advice or exercise for chronic whiplash disorders? Design of a randomized controlled trial.

Authors:  Mark J Stewart; Christopher G Maher; Kathryn M Refshauge; Rob D Herbert; Nikolai Bogduk; Michael Nicholas
Journal:  BMC Musculoskelet Disord       Date:  2003-08-21       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.